SOX4 and colonic neoplasm: Expression of SOX4 or PIK2C2B leads to MGH-CP1 resistance, with SOX4 showing strong effects in Huh7 cells, while PIK2C2B is more effective in colon cancer cell lines (HCT116 and DLD1) (Fig. 5e, f and Supplementary Fig. 6e).